Polymorphisms (45TT, 276GT/TT) in the gene encoding adiponectin, involved in hepatic and peripheral glucose metabolism, independently predict liver disease severity in NASH by hepatic steatosis and necro-inflammatory grade along with postprandial adiponectin levels [38]. The gene discussed is ADIPOQ; the disease is metabolic dysfunction-associated steatohepatitis.